Lucid Diagnostics LUCD
NASDAQ LUCD
$0.84 -0.06 (-6.29%)
As of: Sep 9, 2026 · 2:26 PM EDT

Lucid Diagnostics (LUCD) EPS (Basic) Growth (3y) (2023 - 2026)

Analysis

Lucid Diagnostics (LUCD) EPS (Basic) Growth (3y) (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) Growth (3y) (Qtr)
1 Natera 47.12 Bn 46.02 Bn 486.15 Mn 21.74%
2 Labcorp Holdings 26.25 Bn 26.10 Bn 1.11 Bn 19.75%
3 Quest Diagnostics 26.02 Bn 25.40 Bn 1.03 Bn 10.55%
4 Guardant Health 21.89 Bn 20.84 Bn 219.03 Mn -10.58%
5 Tempus AI 11.21 Bn 10.39 Bn 274.25 Mn 26.92%
6 Caris Life Sciences 6.94 Bn 6.14 Bn 182.38 Mn -
7 Sotera Health 5.22 Bn 4.86 Bn 177.96 Mn 30.89%
8 BillionToOne 4.75 Bn 4.20 Bn 77.11 Mn -
9 iRhythm Holdings 3.98 Bn 3.39 Bn 163.21 Mn 73.26%
10 Lucid Diagnostics 153.93 Mn 120.53 Mn 55,000.00 33.40%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 33.40%
Mar 31, 2026 24.80%
Dec 31, 2025 27.10%
Sep 30, 2025 37.52%
Jun 30, 2025 42.03%
Mar 31, 2025 -14.44%
Dec 31, 2024 27.83%
Sep 30, 2024 20.72%
Jun 30, 2024 19.44%
Mar 31, 2024 -15.84%
Dec 31, 2023 -10.26%
Sep 30, 2023 -33.32%